Clinical Implications of Naples Prognostic Score for Patients with Resected Cholangiocarcinoma: A Real-World Experience

被引:4
|
作者
Xu, Benjie [1 ]
Zhu, Jiahao [1 ]
Wang, Ren [1 ]
Pang, Xiangyi [1 ]
Wang, Xin [1 ]
Lian, Jie [1 ,2 ]
Lu, Haibo [1 ,2 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Outpatient Chemotherapy, Harbin, Peoples R China
[2] Harbin Med Univ, Canc Hosp, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Naples prognostic score; cholangiocarcinoma; nomogram; overall survival; real-world experience; INFLAMMATION;
D O I
10.2147/JIR.S446735
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: The Nutritional Prognostic Score (NPS) is a composite indicator that effectively reflects the preoperative nutritional and inflammation status of patients. Its prognostic value has been extensively confirmed in various types of tumors. Our study aims to investigate the clinical implications of the NPS in the postoperative patients with cholangiocarcinoma (CCA). Patients and Methods: Data on clinicopathological characteristics were collected from CCA patients who underwent radical surgery between 2014 and 2019 at Harbin Medical University Cancer Hospital. NPS was calculated using relevant indicators to categorize the patients, and association of NPS with clinicopathological characteristics and survival outcomes were analyzed. To assess differences in survival rates between different groups, we utilized the Kaplan -Meier method. Independent prognostic risk factors were identified by Cox regression analysis. A CONomogram was created, and its accuracy in survival prediction was evaluated using receiver operating characteristic (ROC) curves. Independent verification was conducted in the validation group. Results: For this study, a cohort of 232 patients was enlisted and subsequently divided into training group (N=162) and validation group (N=70). An evident correlation was detected between NPS and preoperative malnutrition. Patients with higher NPS exhibited a worse overall survival (OS), with 5 -year OS rates of 79.1%, 33.1%, and 10.6%. Multivariate analysis revealed that NPS was an independent risk factor for OS in resected CCA patients (P<0.001). The NPS-based Nomogram was developed to accurately assess the risk of patients. Conclusion: The NPS was identified as a significant risk factor that impacts the prognosis of patients with resected CCA. In order to improve prognosis management, the NPS-based Nomogram has been demonstrated to be a precise and efficient tool.
引用
收藏
页码:655 / 667
页数:13
相关论文
共 50 条
  • [1] Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer
    Nakagawa, Nobuhiko
    Yamada, Suguru
    Sonohara, Fuminori
    Takami, Hideki
    Hayashi, Masamichi
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (03) : 887 - 895
  • [2] Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer
    Nobuhiko Nakagawa
    Suguru Yamada
    Fuminori Sonohara
    Hideki Takami
    Masamichi Hayashi
    Mitsuro Kanda
    Daisuke Kobayashi
    Chie Tanaka
    Goro Nakayama
    Masahiko Koike
    Michitaka Fujiwara
    Yasuhiro Kodera
    Annals of Surgical Oncology, 2020, 27 : 887 - 895
  • [3] Prognostic value of the Naples prognostic score in patients with intrahepatic cholangiocarcinoma after hepatectomy
    Du, Cheng-Fei
    Gao, Zhen-Yu
    Xu, Zhu-Ding
    Fang, Zheng-Kang
    Yu, Zi-Chen
    Shi, Zhe-Jin
    Wang, Kai-Di
    Lu, Wen-Feng
    Huang, Xiao-Kun
    Jin, Lei
    Fu, Tian-Wei
    Shen, Guo-Liang
    Liu, Jun-Wei
    Zhang, Cheng-Wu
    Huang, Dong-Sheng
    Liang, Lei
    BMC CANCER, 2024, 24 (01)
  • [4] Prognostic Factors Associated with Resected Osteosarcoma: Efficacy of Adjuvant Setting, Real-World Experience
    Majidova, Nargiz
    Simsek, Fatih
    Biter, Sedat
    Yaslikaya, Sendag
    Seyyar, Mustafa
    Duygulu, Mustafa Emre
    Arcagok, Murat
    Kircali, Muhammed Fatih
    Sever, Nadiye
    Kocaaslan, Erkam
    Erel, Pinar
    Agyol, Yesim
    Guren, Ali Kaan
    Celebi, Abdussamet
    Arikan, Rukiye
    Isik, Selver
    Ercelep, Ozlem
    Sari, Murat
    Bayoglu, Ibrahim Vedat
    Kostek, Osman
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (01): : 20 - 27
  • [5] FGFR Inhibitors in Cholangiocarcinoma: A Real-World Experience at a Tertiary Center
    Rizzo, Alessandro
    Brandi, Giovanni
    JCO PRECISION ONCOLOGY, 2022, 6
  • [6] Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence
    Qin-qin Liu
    Xiang-de Shi
    Yan-fang Ye
    Qi-bin Tang
    Hao-ming Lin
    Xian-huan Yu
    Rui Zhang
    Chao Liu
    Cancer Immunology, Immunotherapy, 2023, 72 : 1753 - 1761
  • [7] Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence
    Liu, Qin-qin
    Shi, Xiang-de
    Ye, Yan-fang
    Tang, Qi-bin
    Lin, Hao-ming
    Yu, Xian-huan
    Zhang, Rui
    Liu, Chao
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1753 - 1761
  • [8] Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma
    Feng, Ji-Feng
    Zhao, Jian-Ming
    Chen, Sheng
    Chen, Qi-Xun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Real-World Evaluation of the CF-Able Score as a Clinical Prognostic Tool in Cystic Fibrosis
    McElvaney, O. J.
    McCarthy, C.
    Gunaratnam, C.
    Reeves, E. P.
    McElvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [10] Real-world clinical management of CTEPH patients - a single center experience
    Rosenstock, Piet
    Avian, Alexander
    Douschan, Philip
    Foris, Vasile
    Pienn, Michael
    Sassmann, Teresa
    Olschewski, Horst
    Kovacs, Gabor
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 (19-20) : 525 - 525